CMI
ABBV icon

Clare Market Investments’s AbbVie ABBV Stock Holding History

Clare Market Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$352K Buy
1,398
+12
+0.9% +$2.58K 0.06% 142
2026
Q1 		$302K Buy
+1,386
New +$307K 0.06% 140
2025
Q3 		$316K Buy
1,367
+11
+0.8% +$2.24K 0.06% 128
2025
Q2 		$252K Buy
1,356
+12
+0.9% +$2.23K 0.06% 127
2025
Q1 		$281K Sell
1,344
-122
-8% -$23.7K 0.07% 109
2024
Q4 		$260K Buy
1,466
+14
+1% +$2.57K 0.06% 124
2024
Q3 		$287K Buy
1,452
+11
+0.8% +$2.05K 0.08% 123
2024
Q2 		$247K Buy
1,441
+14
+1% +$2.32K 0.07% 123
2024
Q1 		$260K Buy
1,427
+13
+0.9% +$2.24K 0.08% 130
2023
Q4 		$219K Buy
1,414
+15
+1% +$2.19K 0.08% 133
2023
Q3 		$209K Buy
+1,399
New +$205K 0.08% 123
2023
Q2 		– Sell
-1,647
Closed -$262K – 131
2023
Q1 		$262K Buy
1,647
+188
+13% +$28.7K 0.11% 101
2022
Q4 		$236K Buy
+1,459
New +$224K 0.11% 108
2022
Q3 		– Sell
-1,433
Closed -$219K – 125
2022
Q2 		$219K Sell
1,433
-5,562
-80% -$850K 0.1% 114
2022
Q1 		$1.13M Buy
6,995
+984
+16% +$143K 0.36% 38
2021
Q4 		$814K Buy
6,011
+75
+1% +$8.86K 0.23% 57
2021
Q3 		$640K Sell
5,936
-770
-11% -$88K 0.19% 63
2021
Q2 		$755K Buy
6,706
+2,121
+46% +$239K 0.24% 58
2021
Q1 		$497K Buy
4,585
+1,516
+49% +$162K 0.19% 63
2020
Q4 		$329K Sell
3,069
-8
-0.3% -$769 0.14% 83
2020
Q3 		$270K Buy
+3,077
New +$290K 0.13% 85

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Clare Market Investments's ABBV Position: Q2 2026 in Review

Clare Market Investments increased its AbbVie (ABBV) stake by 0.87% in Q2 2026, buying an estimated $2.58K and bringing the position to 1,398 shares worth $352K. The position accounts for 0.06% of the portfolio, ranked #142.

Clare Market Investments first reported a position in ABBV in Q3 2020 and has held it in 21 quarters since. The position peaked at $1.13M in Q1 2022. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Clare Market Investments held 1,398 shares of AbbVie worth $352K as of Q2 2026.
  • Clare Market Investments bought 12 AbbVie shares in Q2 2026, an estimated $2.58K.
  • AbbVie made up 0.06% of Clare Market Investments's portfolio in Q2 2026, its #142 holding.
  • Clare Market Investments first reported a position in AbbVie in Q3 2020 and has held it in 21 quarters since.
  • Clare Market Investments's AbbVie position peaked at $1.13M in Q1 2022.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Clare Market Investments's 13F filing for Q2 2026, filed 27 Jul 2026.